Contact Investor Relations

antibody-600
  • Questions regarding our publicly traded stock? Questions about this section of the website? Please complete the form and we’ll be in touch as soon as possible.

    Thank you for your interest in Nascent Biotech.


Delivering human antibodies for the treatment of cancer